# Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia

> **NCT07298824** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 164 (estimated)

## Conditions studied

- Myopia Progressing

## Interventions

- **BIOLOGICAL:** Investigational Bifidobacterium Preparation MR-61
- **OTHER:** Placebo for MR-61

## Key facts

- **NCT ID:** NCT07298824
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298824, "Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07298824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*